---
schema_version: "secwatch.filing_event.v1"
accession: "0001816590-26-000059"
form_type: "8-K"
ticker: "CMPS"
cik: "0001816590"
company_name: "COMPASS Pathways plc"
filed_at: "2026-08-05T10:31:09+00:00"
generated_at: "2026-08-05T10:35:58.436577+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Compass Pathways reports Q2 2026 net loss of $253.8M; COMP360 NDA on track for Q4

## Summary
- Q2 net loss $253.8M ($1.88/share) vs $38.4M in Q2 2025; increase from non-cash warrant adjustments.
- Cash and equivalents $433.3M as of June 30, 2026, up from $149.6M at Dec 31, 2025; expected to fund operations into 2028.
- Rolling NDA submission for COMP360 in TRD underway; final submission expected Q4 2026; commercial launch targeted H1 2027.
- Positive Phase 3 data showed rapid onset and durable benefit through 6 months; COMP360 expected to be blockbuster if approved.
- R&D expenses $29.2M in Q2 2026 vs $30.3M in Q2 2025; G&A increased to $23.2M from $12.6M due to commercial prep.

## SEC filing metadata
- accession: 0001816590-26-000059
- form_type: 8-K
- ticker: CMPS
- cik: 0001816590
- company_name: COMPASS Pathways plc
- filed_at: 2026-08-05T10:31:09+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1816590/000181659026000059/0001816590-26-000059-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1816590/000181659026000059/cmps-20260805.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001816590-26-000059
- JSON: https://secwatch.observer/filing/0001816590-26-000059.json
- Plain text: https://secwatch.observer/filing/0001816590-26-000059.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.